Effects of metformin and glibenclamide on serum MDA level. The results are expressed as mean±SD.* indicates statistically significant differences in contrast to newly diagnosed group (***p < 0.001); # indicates statistically significant differences between treated groups (##p < 0.01), as determined by Kruskal-Wallis test followed by a Dunn’s multiple comparisons post-hoc test.